Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
about
Iron supplementation for reducing morbidity and mortality in children with HIVIron supplementation for reducing morbidity and mortality in children with HIVA prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South AfricaHIV/Hepatitis C Virus-Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders DoAssessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study.Pathogenesis of HIV-1 infection within bone marrow cells.Cerebellar degeneration and immune thrombocytopenic purpura associated with human immunodeficiency virus infection (HIV).HIV associated thrombocytopenia, misdiagnosed as thrombotic thrombocytopenic purpura: a case report.CMV-related thrombocytopenia treated with foscarnet: a case series and review of the literature.Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy.Clinical course of children with HIV associated thrombocytopenia.Hematologic abnormalities associated with simian immunodeficieny virus (SIV) infection mimic those in HIV infection.Haematological changes in HIV infection with correlation to CD4 cell count.Immune thrombocytopenic purpura: a presentation of HIV infection.Bone marrow abnormalities in HIV infected children, report of three cases and review of the literature.Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.Prevalence of thrombocytopenia among Chinese adult antiretroviral-naïve HIV-positive patients.Prevalence of HIV-related thrombocytopenia among clients at Mbarara Regional Referral Hospital, Mbarara, southwestern UgandaPlatelets Contribute to BBB Disruption Induced by HIV and Alcohol.Effect of malaria infection on hematological profiles of people living with human immunodeficiency virus in Gambella, southwest Ethiopia.Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced childrenA review of the use of blood and blood products in HIV-infected patientsPlatelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, CameroonPrevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia.Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infection.Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients.Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.Decreased CD10 Expression in the Bone Marrow Neutrophils of HIV Positive PatientsManagement of anemia of chronic disease in patients with the human immunodeficiency virus.The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries.Predictors of anaemia and iron deficiency in HIV-infected pregnant women in Tanzania: a potential role for vitamin D and parasitic infectionsHyperhomocysteinemia in HIV-Infected Individuals: Correlation of a Frequent Prothrombotic Factor with CD4+ Cell Count.The evolution of haematological and biochemical indices in HIV patients during a six-month treatment period.Neutropenia during HIV infection: adverse consequences and remedies.Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.Anemia in HIV infection: clinical impact and evidence-based management strategies.Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.Altered iron metabolism in children with human immunodeficiency virus disease.
P2860
Q24241298-7DBEF9D8-5159-47FC-8A56-E4DFA3E6A0FBQ24244907-5A32D1B2-E390-4012-A214-735F03671C8EQ24802413-2A9394A2-54B0-4135-ADB9-BD7885B2B3FFQ27491342-A31B4E2B-BA93-48E7-87B4-D661ED4118B2Q30530815-4AAB58C4-7EE2-4558-A218-0B3645A8E920Q33334766-0C1D2D2B-D46F-4BC6-8752-10021806F2F6Q33377886-79CE8AB2-5A42-40B6-A1AC-9CDAF51F41E3Q33387225-211C10B8-2A55-4C28-9924-723112ADEE79Q33390694-F54B1A88-858F-4B3B-AA83-83E8E7FCD9D1Q33395500-377DD3E9-B3D1-41F4-B33C-1D027F6174E6Q33398449-B607A835-5F00-4B94-B2B6-81458DB9F303Q33401379-70DE93BB-AC40-4D1B-99BF-039ABDBE7F73Q33403155-0BEED126-6193-4385-9BAC-CF8C469B7534Q33403956-EF9ECE9C-0FD5-4424-9D00-7B6BAB06B3F6Q33414937-BC9A18C3-F6CC-49D9-895A-26AC938F4BF5Q33417606-2AFEC6A9-F094-4D55-9621-B0E3F358A67AQ33420327-5CAF4276-3BB9-4D9A-9741-30228F2E9C22Q33422442-38013944-1F8C-4D63-968F-A366A38BBB30Q33427030-8B47EA53-143E-452F-8083-F129640CB410Q33439223-CE8AD010-FC96-455C-BE48-4A22CA9E9F62Q33439843-0CC676F5-CBC8-4099-9A81-8D6F545392AFQ33643448-D11F18D1-EF87-40AC-8545-3BE5F9DB4F10Q33987093-4FF11E65-13E9-414E-B8C4-ED05EBFB60B9Q34184672-F07E1602-5D3A-4A63-A0DC-B6009E6292D5Q34251519-131B7D5E-669F-4659-A030-C6B463FA0212Q34631656-9AB2BFD9-F0FB-4451-8864-64425E7E9496Q34631679-46D84716-61B4-4F54-ADE2-F9C7D62C14CFQ34973435-97D78539-6445-42AA-9432-0AA1AC1E1471Q35098988-EB3ADE0F-411C-4F74-8640-86A63A030784Q35585229-11A3B4DA-2B63-460D-8D71-B7406D3B589AQ35915467-D8F2BDCA-BFE1-4AAF-9B6B-A0896DA88955Q36004844-585DF599-381F-4888-BD3B-B72DF55DEBDBQ36088592-A4D1436D-207F-4646-A364-3CEE615986A8Q36292309-0F27ACA4-0C3D-46AD-9C7A-F0D0952730AEQ36919713-63330773-827E-49F8-8F37-8FA52D323A5AQ37437356-694D3F7F-8199-4FA0-B60D-9B713DCC3E13Q38649363-B89180E2-9C89-4422-A32F-64BB2C6E7859Q40508851-934B42DC-4D6A-43BF-90F9-0DDC9115F061Q41497115-222E924E-A7FD-4484-BF64-463CE0E5BD5DQ44359583-11E2D170-E71D-4595-ADA4-4EDED8AE808A
P2860
Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Hematologic complications of h ...... red immunodeficiency syndrome.
@ast
Hematologic complications of h ...... red immunodeficiency syndrome.
@en
type
label
Hematologic complications of h ...... red immunodeficiency syndrome.
@ast
Hematologic complications of h ...... red immunodeficiency syndrome.
@en
prefLabel
Hematologic complications of h ...... red immunodeficiency syndrome.
@ast
Hematologic complications of h ...... red immunodeficiency syndrome.
@en
P1476
Hematologic complications of h ...... red immunodeficiency syndrome.
@en
P2093
P304
P356
10.1016/S0025-7125(05)70526-5
P577
1997-03-01T00:00:00Z